Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Medtronic PLC, consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel
Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021 Apr 30, 2021 Jan 29, 2021 Oct 30, 2020 Jul 31, 2020 Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017
Cash and cash equivalents 1,623 1,311 1,339 1,543 4,521 4,828 2,140 3,714 3,479 2,900 3,004 3,593 5,077 6,420 6,499 4,140 3,709 3,962 5,080 4,393 3,703 3,911 4,380 3,669 6,358 5,529 4,691
Investments 6,698 6,423 6,537 6,416 6,616 6,602 6,733 6,859 7,742 7,769 7,591 7,224 9,562 7,857 6,513 6,808 7,919 6,436 5,603 5,455 5,439 6,222 6,624 7,558 8,078 7,997 8,397
Accounts receivable, less allowances and credit losses 5,968 5,934 5,806 5,998 5,887 5,626 5,308 5,551 5,446 5,493 5,431 5,462 5,215 5,348 4,876 4,645 6,248 6,118 5,894 6,222 5,854 5,743 5,674 5,987 5,775 5,752 5,784
Inventories, net 5,726 5,754 5,668 5,293 5,375 5,055 4,809 4,616 4,514 4,349 4,288 4,313 4,508 4,484 4,551 4,229 4,122 4,042 3,932 3,753 3,866 3,763 3,681 3,579 3,751 3,638 3,538
Other current assets 2,498 2,659 2,519 2,425 2,965 3,287 3,145 2,319 2,122 2,220 2,120 1,956 1,985 1,927 2,070 2,209 2,045 2,095 2,196 2,144 2,015 2,014 2,101 2,187 2,645 2,246 2,000
Current assets held for sale 369
Current assets 22,513 22,081 21,869 21,675 25,364 25,398 22,135 23,059 23,303 22,731 22,434 22,548 26,347 26,036 24,509 22,031 24,043 22,653 22,705 21,967 20,877 21,653 22,460 22,980 26,607 25,162 24,779
Property, plant, and equipment, net 5,838 5,735 5,665 5,569 5,437 5,298 5,281 5,413 5,251 5,188 5,162 5,221 5,023 4,938 4,882 4,828 4,764 4,756 4,711 4,675 4,593 4,536 4,524 4,604 4,517 4,441 4,387
Goodwill 41,160 40,821 41,436 41,425 41,565 40,417 40,324 40,502 41,346 41,612 41,720 41,961 42,141 41,212 40,714 39,841 40,091 39,952 40,082 39,959 40,003 38,605 38,955 39,543 39,795 39,077 39,196
Other intangible assets, net 13,690 14,060 14,434 14,844 15,265 15,655 15,775 15,595 16,078 16,523 16,890 17,740 18,240 18,412 18,670 19,063 19,456 19,775 20,234 20,560 20,835 20,819 21,270 21,723 22,178 22,625 23,006
Tax assets 3,599 3,428 3,461 3,477 3,361 3,350 3,311 3,403 3,309 3,203 3,187 3,169 3,310 3,176 2,988 2,832 2,272 1,804 1,545 1,519 1,496 1,414 1,413 1,465 1,537 1,749 1,598
Other assets 4,036 3,962 3,911 3,958 3,142 3,123 3,088 3,009 2,517 2,499 2,409 2,444 2,209 2,112 2,143 2,094 2,196 2,113 1,991 1,014 926 1,123 1,099 1,078 1,166 1,404 1,284
Noncurrent assets held for sale 6,000
Noncurrent assets 68,323 68,006 68,907 69,273 68,770 67,843 67,779 67,922 68,501 69,025 69,368 70,535 70,923 69,850 69,397 68,658 68,779 68,400 68,563 67,727 67,853 66,497 67,261 68,413 69,193 69,296 75,471
Total assets 90,836 90,087 90,776 90,948 94,134 93,241 89,914 90,981 91,804 91,756 91,802 93,083 97,270 95,886 93,906 90,689 92,822 91,053 91,268 89,694 88,730 88,150 89,721 91,393 95,800 94,458 100,250

Based on: 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31), 10-K (reporting date: 2020-04-24), 10-Q (reporting date: 2020-01-24), 10-Q (reporting date: 2019-10-25), 10-Q (reporting date: 2019-07-26), 10-K (reporting date: 2019-04-26), 10-Q (reporting date: 2019-01-25), 10-Q (reporting date: 2018-10-26), 10-Q (reporting date: 2018-07-27), 10-K (reporting date: 2018-04-27), 10-Q (reporting date: 2018-01-26), 10-Q (reporting date: 2017-10-27), 10-Q (reporting date: 2017-07-28).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Medtronic PLC current assets increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Property, plant, and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Medtronic PLC property, plant, and equipment, net increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Medtronic PLC noncurrent assets decreased from Q1 2024 to Q2 2024 but then slightly increased from Q2 2024 to Q3 2024.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Medtronic PLC total assets decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 exceeding Q1 2024 level.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Medtronic PLC cash and cash equivalents decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 exceeding Q1 2024 level.
Investments Amount of investment in marketable security, classified as current. Medtronic PLC investments decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 exceeding Q1 2024 level.
Accounts receivable, less allowances and credit losses Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Medtronic PLC accounts receivable, less allowances and credit losses increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Inventories, net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Medtronic PLC inventories, net increased from Q1 2024 to Q2 2024 but then slightly decreased from Q2 2024 to Q3 2024.